Prospective Elimination Of Distal Coronary Sinus-Left Atrial Connections for Atrial Fibrillation Ablation Trial



Status:Recruiting
Conditions:Atrial Fibrillation, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:8/26/2018
Start Date:August 18, 2018
End Date:August 2021
Contact:Ling Kuo, M.D.
Email:Ling.Kuo@uphs.upenn.edu
Phone:267-265-8173

Use our guide to learn which trials are right for you!

Atrial fibrillation (AF) is the most common cardiac arrhythmia affecting millions of people
in the US and around the world. Over the last 20 years, catheter based AF ablation has been
widely adopted offering improved symptom control for many patients worldwide. However,
long-term success rates remain suboptimal. Prior work indicates that distal connections
between coronary sinus musculature and the left atrium exist and provide a substrate for
single or multiple reentry beats as a trigger for atrial fibrillation. In this trial, the
investigators will examine the efficacy of elimination of distal connection(s) between
coronary sinus and left atrial musculature for suppression of recurrent atrial arrhythmias.

Atrial fibrillation (AF) is the most common cardiac arrhythmia affecting millions of people
in the US and around the world. Over the last 20 years, catheter based AF ablation has been
widely adopted. However, long-term success rates fhave been reported to be as low as 50% and
20% for paroxysmal and persistent AF, respectively. To achieve permanent arrhythmia
suppression, repeated ablation procedures are often needed. Prior work indicates that distal
connections between coronary sinus musculature and the left atrium provide a substrate for
single or multiple reentry beats as a trigger for atrial fibrillation. In this prospective
randomized trial the investigators will define the efficacy of elimination of distal
connections between coronary sinus and left atrial musculature for suppression of recurrent
atrial arrhythmias. Patients will be randomly assigned to standard of care ablation
(pulmonary vein isolation and non pulmonary vein trigger ablations) alone, or standard of
care ablation augmented by distal coronary sinus to left atrial connection elimination.

Inclusion Criteria:

- Patients with paroxysmal or persistent atrial fibrillation; AND Undergoing first AF
ablation; AND Age ≥ 18 years.

Exclusion Criteria:

- Previous left atrial ablation; Women currently pregnant; Mental or physical inability
to take part in the study; Known terminally ill patients.
We found this trial at
1
site
3400 Spruce St
Philadelphia, Pennsylvania 19104
 (215) 662-4000
Phone: 215-615-5220
Hospital of the University of Pennsylvania The Hospital of the University of Pennsylvania (HUP) is...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials